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G-F 20 is also approved in the European Union and several other 
countries for treating osteoarthritis pain of the hip and is under 
an FDA approved investigational study for the hip as well. Be- 
cause injecting directly into the hip joint space is difficult, a con- 
trast agent is first injected to facilitate subsequent injection of the 
viscosupplement using fluoroscopic guidance. 
The purpose of this study was to determine the in vitro compat- 
ibility of hylan G-F 20 with commercially-available f uoroscopic 
contrast agents. Compatibility was defined as no change in rhe- 
ological properties, pH, appearance or chemical structure of the 
contrast agents and hylan G-F 20 mixtures when compared to a 
control (saline added to hylan G-F 20). 
Ionic dimer ioxaglate and non-ionic monomer iohexol represent 
the two classes of contrast agents used clinically and were cho- 
sen for investigation in this study. 
Methods: Ioxaglate or iohexol was aseptically mixed with hylan 
G-F 20 or saline at a 2:1 volume ratio. Following mixing, the sam- 
ples were stored at 37°C for 24, 48 and 72 hours and were eval- 
uated for the storage (G l) and loss modulii (G'), and viscosity. 
Contrast agent recovery, representing agent compatibility follow- 
ing mixing with hylan G-F 20, was analyzed by capillary zone 
electrophoresis (CZE). Each sample was tested in triplicate. 
Results: Dilution with either contrast agent did not adversely ef- 
fect hylan G-F 20 G' when compared to the saline control over 
3 days at 37°C (Fig. 1). Capillary zone electrophoresis analysis 
showed no change in elution time and good recovery (Fig. 2) of 
the contrast agents after mixing with hylan G-F 20 and incubation. 
Conclusions: We conclude that contrast agents used for hip in- 
jections are compatible with hylan G-F 20. We did not see any 
change in rheological properties, pH, and appearance of the con- 
trast agents and hylan G-F 20 mixtures when compared to a con- 
trol (saline added to hylan G-F 20). 
Additionally, we did not observe any significant change in contrast 
agent recovery or chemical interactions of contrast agents with 
hylan G-F 20. 
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Introduction: High tibial osteotomy (HTO) is recommended for 
people with moderate to severe medial knee OA (MKOA) to avoid 
or delay joint replacement. HTO is effective in restoring knee func- 
tion and reducing pain however many patients with good initial 
surgical outcomes continue developing pain and joint destruc- 
tion. The aim of this study was to investigate the effect of HTO 
on movement patterns in people with MKOA, focusing on charac- 
teristics affecting disease progression. 
Methods: Nine subjects with MKOA and genu varum were tested 
prior to (PRE) and at one (P1) and two (P2) years after HTO. Nine 
healthy controls with neutral alignment (NORM) were compared. 
Motion analysis was performed to assess kinematic and kinetic 
patterns during the stance phase of gait. Alignment and joint lax- 
ity were measured from radiographs. Quadriceps strength was 
assessed isometrically. Self-reported knee function and instability 
were analyzed. Independent -tests, paired t-tests and one-way 
ANOVA's for repeated measures were used to assess differences 
in groups and time frames. 
Results: After HTO the improved alignment, reduced laxity and 
reduced knee adduction angles and moments during walking re- 
mained unchanged after 2 years. Quadriceps strength was lower 
post-operatively and was lower than controls at 1 and 2 years 
(p=0.006). Knee flexion remained lower than controls (p= 0.049). 
Self-reported knee function improved but remained significantly 
lower than controls. Prior to surgery 6/9 subjects (67%) com- 
plained of knee instability and 5 reported improved stability af- 
ter 1 year. After 2 years, two subjects instability worsened and 
quadriceps weakness correlated with knee instability (r=0.576, 
p=0.056). 
Discussion: Improved alignment and laxity and reduced ad- 
duction angles and moments during walking persisted after two 
years. However, quadriceps strength and knee flexion during 
weight acceptance did not improve. Quadriceps weakness has 
been associated with reduced knee flexion during gait that could 
reduce shock absorption and hasten joint destruction. Quadri- 
ceps strength has also been associated with higher knee func- 
tion and may reduce the progression of MKOA. Yet rehabilitation 
to address quadriceps weakness following HTO is uncommon. 
Our work shows that people with MKOA complain of knee insta- 
bility that may be associated with high shear forces that are detri- 
mental to articular cartilage. Surgical realignment was successful 
at mitigating knee instability at one year but instability worsened 
thereafter. The correlation between quadriceps trength and knee 
instability suggests that despite realignment persistent weakness 
and instability could contribute to further joint degeneration. Re- 
habilitation, both non-operative and after HTO, should focus on 
quadriceps strength and improving joint stability to improve the 
long term function of people with MKOA. 
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Aim of the study: To investigate the effects of High Intensity 
Laser Therapy (HILT) as a new non- invasive method to stimu- 
late articular cartilage repair in vivo. 
Methods: Full thickness defects reaching the subchondral bone 
were created by mean of a surgical drill in the weight-bearing 
surface of the lateral femoral condyle of six sheeps. The wounds 
were then repaired using a new laser system (HILT): 3 out of the 
six sheeps received the laser treatment the other three were used 
as controls. 
Each treated subjetc received 15 treatments in 3 weeks of HILT 
laser system by EI.En. Group (Itlay). In our protocol we delivered 
19 kW/cm 2 of peak intensity and 2.5 J/cm 2 of fluence. 
To verify the efficacy of the treatment the cartilage tissues 
from the different animals were analysed at 21 (T1), 45 (T2) 
and 90 (T3) days by histological and immunohistological nal- 
yses. In particular the samples were stained with Safranin-O, 
Haematoxylin-Eosin, Alcian Pas and Herovici's stain. Mono and 
polyclonal antibodies specific to Vimentine, Ki67, ILGF-1, IL-lb, 
MMP-12 and collagen type I and II, were employed for immuno- 
histochemical evaluations. 
Results: The macroscopic observation of the defect areas 
showed a progressive growth of a new tissue from the edges to 
the central area of the lesions in the sheep treated with HILT. At 
T1 it was possible to evidentiate an increase in chondrocyte pro- 
liferation (high expression of ILGF 1 and Ki67) and a decrease 
of inflammatory factors (IL-1 b, MMP-1). On the contrary the con- 
trol group showed a severe tissue inflammation. At T/2 and T/3 
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we observed the formation of a new tissue with some features 
of hyaline cartilage either for the presence of collagen type II ex- 
pression or the morphological appearance. We could observe the 
spatial distribution of collagen fibres according to Benningoff's 
scheme. 
Conclusion: These preliminary data indicate that HILT was able 
to induce a physiological repair of deep and severe osteochon- 
dral lesions in an animal model. The quality of the newly formed 
tissue was excellent in terms of shape and morphological distri- 
bution of isogenic groups, type and spatial distribution of collagen 
fibres and physical-chemical composition of extracellular matrix. 
Moreover, the centripetal growth of cartilage, from edges to the 
central areas of the created lesions, suggest that the proliferation 
of chondrocytes is faster than the proliferation of mesenchymal 
cells of the subchondral bone. These results advocate the use 
of HILT treatment for further in vivo studies and finally, in human 
clinical trials for the treatment of knee cartilage defects. 
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Introduction: Substance P (SP) is a neuropeptide found at in- 
creased concentrations in inflamed joints and believed to play 
a key role in joint pain and pathology. Sensory nerve termi- 
nals containing SP have been identified in the synovium, liga- 
ments, tendons, menisci and the osteochondral junction in os- 
teoarthritic joints. Recent studies have also shown that chon- 
drocytes express SP receptors, however, the mechanism of SP 
action on chondrocytes remains unknown. Chondrocytes exhibit 
large (greater than 100 mS/F) voltage-gated potassium currents 
(Kv), and studies in nerve and muscle show these to be a poten- 
tial target for SP modulation. 
Aim of Study: In the present study electrophysiology was used 
to determine the effects of SP on potassium currents in equine 
articular chondrocytes. 
Methods: We used whole-cell patch-clamp recording from first- 
expansion and first-passage equine chondrocyte in conventional 
physiological solutions. 
Results: We found equine articular chondrocyte Kv currents to 
be insensitive to dendrotoxin-I, but blocked by both tetraethylam- 
monium and 4-aminopyridine (2.64-0.6mM (n=6) and1.34-0.7 mM 
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Fig. 1. Histogram of chondrocyte Kv currents produced following application 
of 4-aminopyridine, dendrotoxin-I and SP relative to untreated cells (control), 
all at +40mV. 
(n= 5) respectively). Interestingly SP positively modulated equine 
chondrocyte Kv: addition of II~M SP caused a statistically signif- 
icant* (approximately 100%) increase in whole-cell conductance 
at +40mV (p _<0.005, 2-way ANOVA test, n=4) (Fig. 1). Following 
Boltzmann fitting of the data, comparison of V l /2  and k param- 
eters yielded a significant increase in k (p_<0.005, paired t-test, 
n=4) compared with control recordings from the same cell, but no 
significant change in Vl/2. 
Conclusions: To our knowledge, this is the first study of the ef- 
fects of SP on Kv in equine articular chondrocytes. Future studies 
will determine the mechanisms and receptor specificity of this ef- 
fect. 
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Aim of Study: Data on the burden of disease in hand osteoarthri- 
tis (OA) are limited. The objective of the present study was to as- 
sess the disease burden of patients with OA by comparing their 
SF-36 scores with the scores of patients with rheumatoid arthri- 
tis (RA), healthy controls and general population scores and by 
computation of s-scores which allow for comparisons across the 
different SF-36 scales. 
Methods: Female patients between 50 and 70 years of age with 
hand OA (n = 190) and RA (n = 194), referred to our rheumatol- 
ogy department within the preceding two years and healthy con- 
trols (n=144) underwent a thorough clinical examination includ- 
ing completion of the SF-36. The OA and RA patients and the 
controls were compared by their SF- 36 mean scores and also 
by comparing all three groups with normative SF-36 data from an 
age-matched cohort of women representative for the general Nor- 
wegian population. Mean (SD) age in the OA/RA/control groups 
was 61.6 (5.6)/61.1 (6.0)/60.8 (5.7) years, mean age of the gen- 
eral population was 59.2 (6.1). Comparisons were done by one- 
way ANOVA with Tukey post hoc test. Standard difference scores 
(s-scores) to assess the burden of disease were computed by 
subtracting the mean scores of the general population from the 
mean scores of the patients and controls followed by dividing 
these deviations by each scale's standard deviation in the gen- 
eral population. 
Results: Healthy controls had similar scores as the general pop- 
ulation, i.e. s-scores around 0. OA patients had especially re- 
duced health related quality of life in the area of pain, vitality 
and mental health, whereas RA patients especially had deficits 
in physical functioning. 
Table 1. SF-36 scores and s-scores for comparison with general population 
SF-36 scales 
Mean scores S-scores 
OA RA Controls OA RA Controls 
Physical function 57.6 48.4 82.6 -1.35 -1.82 -0.05 
Pain 39.6 44.1 70.9 -1.17 -1.01 -0.03 
General health 51.5 47.5 70.6 -0.90 -1.07 -0.12 
Vitality 40.0 43.3 61.1 -0.91 -0.76 0.07 
Social functioning 67.4 69.2 83.1 -0.77 -0.69 -0.07 
Mental health 68.1 73.3 80.1 -0.58 -0.29 0.09 
Conclusions: Both OA and RA patients experience major impact 
on the subjective health status by their disease as compared to 
healthy controls and general population norms. The consistency 
of the differences between the two patients groups and the two 
